Antibody Discovery

Utilizing multiple technology platforms, LakePharma offers a range of services and solutions to identify novel monoclonal antibodies and determine their sequences. 

1. Hybridoma technology: comprehensive, customized hybridoma campaigns for therapeutic antibody discovery.

2. Naïve phage antibody libraries: LakePharma has licensed multiple naïve Fab libraries (XOMA, Moradec, etc.) and yeast display libraries, and employs them for unparalleled de novo antibody discovery.  

Please contact LakePharma at for custom quotes and details.